查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1918805

艾卡瑞丁技術市場按配方、通路、應用和最終用戶分類 - 全球預測 2026-2032

Icaridin Technical Market by Formulation, Distribution Channel, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年 Icaridin Technologies 市值為 5.0237 億美元，預計到 2026 年將成長至 5.3211 億美元，複合年成長率為 6.62%，到 2032 年將達到 7.8718 億美元。

關鍵市場統計數據
基準年 2025 5.0237億美元
預計年份：2026年 5.3211億美元
預測年份 2032 7.8718億美元
複合年成長率 (%) 6.62%

本文簡要概述了埃卡瑞丁作為一種技術成分：重點介紹其商業性價值、製劑吸引力以及相關人員的決策重點。

本執行摘要為評估伊卡瑞丁作為消費者和機構應用技術成分的相關人員提供必要的背景資訊。伊卡瑞丁是一種用途廣泛的合成驅蟲劑，其優異的理化穩定性和良好的皮膚耐受性使其有別於傳統化學品，重新引起了配方師、零售商和公共衛生採購團隊的注意。以下概要概述了影響近期策略決策的關鍵因素，包括產品特性、分銷趨勢、監管考量和競爭壓力。

配方創新、供應鏈韌性和監管如何協同作用，轉變埃卡瑞丁的研發重點和商業化路徑

隨著配方科學、採購複雜性和消費者期望的交會融合，市場環境發生了顯著變化，研發重點也隨之重塑。研發團隊優先考慮能夠最佳化膚感和持久性的遞送機制，同時最大限度地減少揮發性有機化合物，這推動了配方調整週期，並促進了特種化學品公司和消費品公司之間的合作。同時，採購團隊正透過供應商多元化和協商更長的前置作業時間來解決供應鏈脆弱性問題，並強調可追溯性和上游工程品管。

了解2025年關稅對採購、配方經濟性和分銷合約的累積影響，以維持韌性和利潤管理。

2025年的關稅和貿易政策調整為製造和分銷網路中的採購、定價和供應商選擇帶來了新的考量。傳統上依賴一體化全球供應鏈的公司正在重新評估本地採購方案和雙重採購策略，以降低關稅波動帶來的風險。採購部門正在將關稅情境納入供應商評分卡和總到岸成本模型，這凸顯了製造地柔軟性的重要性。

將產品類型、通路、最終用途需求和應用場景與產品和市場推廣策略連結起來的可操作細分資訊。

細分市場洞察揭示了技術和商業性優先事項的重點所在，從而最大限度地提高產品相關性和通路契合度。基於配方特性，產品團隊必須權衡不同劑型（例如凝膠、乳液、噴霧和擦拭巾）之間的優點和缺點。消費者對不同劑型的感官期望和使用頻率差異顯著，其中噴霧劑型需要特別關注氣霧劑和泵送機制。這些因素會影響推進劑的選擇、氣霧劑的性能和輸送的一致性。這種複雜性要求每種劑型系列都採用不同的開發路徑和監管文件。

區域比較分析重點在於美洲、歐洲、中東和非洲以及亞太市場的監管、消費者和物流促進因素

區域趨勢對基於派卡瑞丁製劑的監管路徑、消費者偏好和物流考量有顯著影響。在美洲，法規結構強調全面的安全文件和清晰的標籤，而分銷生態系統則多元化，涵蓋了成熟的電子商務基礎設施和傳統的零售網路。消費者的接受度受到戶外生活方式趨勢和機構採購慣例強調大包裝和標準化的供應合約。在該地區營運的公司必須最佳化其全通路佈局，以同時觸達休閒用戶和機構買家，並成功應對多層次的聯邦和地方政府監管環境。

競爭格局和能力主導的差異化，造就了原料製造商、消費品牌和合約配方商之間的技術和商業性領先地位。

異戊烯基嘧啶技術領域的競爭動態主要由三類組織構成：提供技術級異戊烯基嘧啶和製劑輔料的特種化學品製造商；將技術原料轉化為成品驅蟲劑的消費品製造商和自有品牌供應商；以及彌合研發與大規模生產之間差距的契約製造製造商和製劑開發商。這些組織透過合成效率、品質保證體系、法規申報和合作開發服務等能力來提升自身競爭力，進而加速產品上市速度。

為製造商和品牌商提供切實可行的策略，以確保供應彈性、擴大配方適應性並建立滿足用戶需求的管道

產業領導者應採取兼顧近期商業化、中期韌性和合規性的投資組合策略。優先投資於可在不同劑型（凝膠、乳液、噴霧劑、擦拭巾等）間互換的配方平台，以最大限度地提高產品柔軟性並縮短開發前置作業時間。同時，深化與供應商的關係，並推廣關鍵中間體的雙重採購，以降低關稅和地緣政治風險，同時保持品管和可追溯性。

我們採用嚴謹的混合方法，結合專家訪談、技術文獻綜述和交叉檢驗的二次分析，來支持我們的結論和建議。

本研究整合了初步訪談、針對性技術審查以及對二級資訊來源的系統性檢驗，以得出可靠的結論。初步研究包括對製劑化學家、採購主管、法規事務專家和零售品類經理進行結構化訪談，以了解營運限制、創新重點和通路經濟效益。技術檢驗包括實驗室層面的數據審查和安全性文件評估，以確認不同劑型的穩定性、皮膚耐受性和包裝相容性。

整合策略重點，使配方柔軟性、供應商多元化和監管準備工作保持一致，從而將技術優勢轉化為市場優勢。

總之，基於派卡瑞丁產品的技術和商業性環境取決於配方創新、供應鏈複雜性和監管審查三者之間的相互作用。投資於適應性強的配方平台、實現採購多元化並加強監管應對力的相關人員，將更有利於將技術優勢轉化為永續的商業性成果。不斷變化的零售通路組合和應用程式特定需求凸顯了產品設計必須與分銷管道的預期和終端用戶的行為相符。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依製劑分類的派卡瑞丁技術市場

  • 凝膠
  • 洗劑
  • 噴
    • 氣霧劑
    • 泵式噴霧
  • 擦拭巾

9. 按分銷管道分類的派卡瑞丁技術市場

  • 線上零售
    • 公司網站
    • 電子商務市場
  • 藥房和藥品商店
    • 連鎖藥局
    • 獨立藥房
  • 專賣店
  • 超級市場和大賣場

第10章 艾卡瑞丁技術市場（依應用分類）

  • 戶外休閒
  • 旅行

第11章 以最終用戶分類的派卡瑞丁技術市場

  • 商業用途
  • 機構使用
  • 個人使用

12. 各地區派卡瑞丁技術市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 艾卡瑞丁技術市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國派卡瑞丁技術市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章美國派卡瑞丁技術市場

第16章 中國派卡瑞丁技術市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aditya Birla Chemicals Pvt. Ltd.
  • Aekyung Petrochemical Co., Ltd.
  • Anhui Huahong Chemical Co., Ltd.
  • Anhui Jinhe Industrial Co., Ltd.
  • Arkema SA
  • Bell Flavors & Fragrances, Inc.
  • Clariant AG
  • Givaudan SA
  • Innospec Inc.
  • Jiangsu Huifeng New Material Co., Ltd.
  • Jiangxi Xinlu Chemical Co., Ltd.
  • Kemin Industries, Inc.
  • LANXESS AG
  • Lonza Group AG
  • Merck KGaA
  • Metran GmbH
  • Privi Speciality Chemicals Ltd.
  • Royal DSM NV
  • Shandong Stevio Bio-Tech Co., Ltd.
  • Solvay SA
  • Symrise AG
  • TCI Chemicals
  • Toagosei Co., Ltd.
  • Vigon International, Inc.
  • Zhejiang Xinan Chemical Industrial Group Co., Ltd.
Product Code: MRR-F14BA1B34044

The Icaridin Technical Market was valued at USD 502.37 million in 2025 and is projected to grow to USD 532.11 million in 2026, with a CAGR of 6.62%, reaching USD 787.18 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 502.37 million
Estimated Year [2026] USD 532.11 million
Forecast Year [2032] USD 787.18 million
CAGR (%) 6.62%

A concise orientation on icaridin as a technical ingredient that clarifies its commercial relevance, formulation appeal, and stakeholder decision priorities

This executive summary frames the essential context for stakeholders evaluating icaridin as a technical ingredient across consumer and institutional applications. Icaridin is positioned as a versatile synthetic repellant whose physicochemical stability and skin tolerability distinguish it from legacy chemistries, prompting renewed interest from formulators, retailers, and public health procurement teams. The following synthesis highlights product attributes, distribution dynamics, regulatory considerations, and competitive pressures that together shape near-term strategic decision points.

The discussion proceeds by linking formulation innovation to channel performance and regional regulatory environments, emphasizing how technical choices cascade into commercial outcomes. Where relevant, we identify structural shifts in supplier ecosystems, entry barriers for new manufacturers, and evolving user preferences that influence adoption. This introduction sets the stage for more detailed sections that distill market motion, tariff impacts, segmentation intelligence, regional variances, competitive behavior, and concrete recommendations for industry leaders.

How formulation innovation, supply chain resilience, and regulatory scrutiny are jointly transforming development priorities and commercial pathways for icaridin

The landscape for icaridin has shifted markedly as formulation science, sourcing complexity, and consumer expectations have converged to reshape development priorities. R&D teams are prioritizing delivery mechanisms that optimize dermal feel and durability while minimizing volatile organics, prompting reformulation cycles and collaboration between specialty chemical producers and consumer goods companies. Concurrently, procurement functions are responding to supply chain fragility by diversifying supplier bases and negotiating longer lead times, with an emphasis on traceability and upstream quality control.

Regulatory emphasis on safety data and labeling has intensified, accelerating demand for robust toxicology dossiers and clarified compliance pathways across jurisdictions. Meanwhile, retail channels have evolved: online platforms are increasing visibility and direct-to-consumer experimentation, while brick-and-mortar outlets emphasize branded trust and convenience. These transformative shifts are creating new opportunities for vertically integrated players and nimble innovators who can translate technical advantages into differentiated consumer experiences.

Navigating the cumulative implications of 2025 tariffs on sourcing, formulation economics, and distribution agreements to sustain resilience and margin control

The introduction of tariffs and trade policy adjustments in 2025 has introduced additional considerations for sourcing, pricing, and supplier selection across manufacturing and distribution networks. Companies that historically relied on integrated global supply lines are reassessing nearshore options and dual-sourcing strategies to reduce exposure to tariff volatility. Procurement teams are incorporating tariff scenarios into supplier scorecards and total landed cost models, elevating the importance of manufacturing footprint flexibility.

From a product development standpoint, tariff-induced cost pressures are accelerating the search for formulation efficiencies that maintain performance while reducing ingredient intensity or enabling concentration adjustments. Additionally, distribution partners are renegotiating commercial terms to share margin impacts and preserve retail price competitiveness. Across all functions, greater emphasis is being placed on scenario planning and contractual mechanisms that hedge against abrupt policy shifts, reinforcing the need for adaptive commercial and operational strategies.

Actionable segmentation intelligence linking formulation types, distribution pathways, end use requirements, and application contexts to product and go-to-market strategy

Segmentation insights illuminate where technical and commercial priorities should be concentrated to maximize product relevance and channel fit. Based on formulation considerations, product teams must assess tradeoffs across gel, lotion, spray, and wipe presentations, recognizing that consumer sensory expectations and application frequency differ significantly; spray formats require additional attention to aerosol and pump delivery mechanics, which affect propellant selection, aerosol performance, and dispensing consistency. This complexity translates into distinct development pathways and regulatory dossiers for each formulation family.

When evaluating distribution strategies, it is critical to align channel characteristics with assortment and pricing models. Online retail offers dynamic merchandising opportunities through company websites and e-commerce marketplaces but demands rapid fulfillment and strong digital marketing. Pharmacy and drug stores, both chain and independent outlets, prioritize clinically credible positioning and trusted packaging claims, while specialty stores and supermarkets emphasize shelf ergonomics and in-store visibility. End users present different performance thresholds: commercial customers focus on bulk stability and handling, institutional buyers require compliance and predictable supply, and personal use consumers prioritize skin feel and ease of application. Application contexts such as outdoor recreation and travel impose distinct duration and residue expectations that inform concentration, excipient selection, and packaging design. Integrating these segmentation layers supports targeted product roadmaps and tailored go-to-market strategies.

Comparative regional intelligence revealing regulatory, consumer, and logistical drivers across Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics materially influence regulatory pathways, consumer preferences, and logistical considerations for icaridin-based formulations. In the Americas, regulatory frameworks emphasize comprehensive safety documentation and labeling clarity, while distribution ecosystems are diverse and include both sophisticated e-commerce infrastructures and legacy retail networks; consumer acceptance is shaped by outdoor lifestyle trends and institutional procurement practices that value large-format packaging and standardized supply contracts. Firms operating here must navigate a mix of federal and subnational regulatory overlays while optimizing omnichannel presence to reach both recreational users and institutional purchasers.

The Europe, Middle East & Africa region presents a mosaic of regulatory regimes and market maturity, with parts of Western Europe demonstrating stringent chemical assessment processes and high consumer sensitivity to ingredient provenance, while other markets prioritize accessibility and cost-effectiveness. Middle Eastern and African markets may place greater emphasis on climate-adapted formulations and scalable distribution models that tolerate longer logistics chains. In the Asia-Pacific region, rapid urbanization and diverse retail modernization trajectories accelerate demand for convenience formats and digitally enabled purchasing; manufacturers should account for varied approval requirements and localized preferences when adapting formulations and packaging to regional climates and usage patterns.

Competitive structure and capability-driven differentiation among ingredient producers, consumer brands, and contract formulators shaping technical and commercial leadership

Competitive dynamics in the icaridin technical space are shaped by three broad categories of organizations: specialty chemical manufacturers who supply technical-grade icaridin and formulation excipients; consumer packaged goods companies and private label suppliers that translate technical ingredients into finished repellents; and contract manufacturers and formulation houses that bridge R&D and scale production. These groups differentiate on capabilities such as synthesis efficiency, quality assurance systems, regulatory submissions, and co-development services that accelerate time to market.

Strategic partnerships and vertical integration are emerging themes as manufacturers seek to secure upstream feedstocks and as brands pursue tighter control over formulation performance. Investment in analytical capacity and toxicological support confers a competitive advantage for companies aiming to supply regulated markets. Additionally, agility in packaging innovation and closed-loop logistics enables competitors to reduce waste and respond more rapidly to seasonal demand cycles, creating opportunities for market entrants that combine technical excellence with commercial execution.

Pragmatic strategic moves for manufacturers and brands to secure supply resilience, broaden formulation adaptability, and align channels with user needs

Industry leaders should adopt a portfolio approach that balances near-term commercialization with medium-term resilience and regulatory alignment. Prioritize investments in formulation platforms that provide interchangeability across gel, lotion, spray, and wipe presentations to maximize SKU flexibility and reduce development lead times. Simultaneously, deepen supplier relationships and pursue dual sourcing for critical intermediates to mitigate tariff and geopolitical exposures while maintaining quality control and traceability.

Commercial teams must tailor channel strategies to the distinct requirements of online retail, pharmacy and drug channels, specialty stores, and supermarkets, aligning packaging, marketing messages, and inventory cadence to the purchasing context. Invest in regulatory intelligence and robust safety dossiers to expedite approvals across jurisdictions and support claims substantiation. Finally, consider strategic alliances with contract manufacturers and logistics partners to scale capacity efficiently and to accelerate entry into priority regions with climate-adapted formulations and locally compliant labeling.

A rigorous mixed-methods approach combining expert interviews, technical dossier review, and cross-validated secondary analysis to underpin conclusions and recommendations

This research synthesizes primary interviews, targeted technical reviews, and systematic secondary-source triangulation to ensure robust and defensible conclusions. Primary research included structured interviews with formulation chemists, procurement leaders, regulatory affairs specialists, and retail category managers to capture operational constraints, innovation priorities, and channel economics. Technical validation encompassed laboratory-grade data review and safety dossier assessments to confirm stability profiles, skin tolerability considerations, and packaging compatibility across delivery forms.

Secondary sources were selected for relevance and credibility, focusing on regulatory texts, peer-reviewed toxicology literature, and industry technical guides. Data synthesis applied cross-validation techniques to reconcile differences between claimed performance and empirically observed behavior, and analysts employed scenario modeling to test how policy changes and supply disruptions could affect supplier selection and product formulation choices. Quality control procedures included expert panel review and document traceability to ensure that recommendations are actionable and rooted in verifiable evidence.

Synthesis of strategic priorities that align formulation flexibility, supplier diversification, and regulatory readiness to translate technical strengths into market advantage

In conclusion, the technical and commercial landscape for icaridin-based products is defined by an intersection of formulation innovation, supply chain complexity, and regulatory scrutiny. Stakeholders that invest in adaptable formulation platforms, diversify sourcing, and strengthen regulatory readiness will be best positioned to convert technical advantages into sustainable commercial performance. The evolving retail mix and application-specific requirements underscore the need to align product design with channel expectations and end-user behaviors.

Moving forward, companies should treat regulatory preparedness and supplier diversification as strategic priorities that complement product innovation. By coupling technical rigor with pragmatic commercial planning, organizations can reduce exposure to policy shocks, respond to changing consumer needs, and capture opportunities presented by new delivery formats and emerging distribution channels. The recommendations outlined here provide a clear pathway for translating technical insight into competitive differentiation and operational resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Icaridin Technical Market, by Formulation

  • 8.1. Gel
  • 8.2. Lotion
  • 8.3. Spray
    • 8.3.1. Aerosol Spray
    • 8.3.2. Pump Spray
  • 8.4. Wipe

9. Icaridin Technical Market, by Distribution Channel

  • 9.1. Online Retail
    • 9.1.1. Company Website
    • 9.1.2. E Commerce Marketplace
  • 9.2. Pharmacy And Drug Stores
    • 9.2.1. Chain Pharmacy
    • 9.2.2. Independent Pharmacy
  • 9.3. Specialty Stores
  • 9.4. Supermarkets And Hypermarkets

10. Icaridin Technical Market, by Application

  • 10.1. Outdoor Recreation
  • 10.2. Travel

11. Icaridin Technical Market, by End User

  • 11.1. Commercial Use
  • 11.2. Institutional Use
  • 11.3. Personal Use

12. Icaridin Technical Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Icaridin Technical Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Icaridin Technical Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Icaridin Technical Market

16. China Icaridin Technical Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aditya Birla Chemicals Pvt. Ltd.
  • 17.6. Aekyung Petrochemical Co., Ltd.
  • 17.7. Anhui Huahong Chemical Co., Ltd.
  • 17.8. Anhui Jinhe Industrial Co., Ltd.
  • 17.9. Arkema S.A.
  • 17.10. Bell Flavors & Fragrances, Inc.
  • 17.11. Clariant AG
  • 17.12. Givaudan SA
  • 17.13. Innospec Inc.
  • 17.14. Jiangsu Huifeng New Material Co., Ltd.
  • 17.15. Jiangxi Xinlu Chemical Co., Ltd.
  • 17.16. Kemin Industries, Inc.
  • 17.17. LANXESS AG
  • 17.18. Lonza Group AG
  • 17.19. Merck KGaA
  • 17.20. Metran GmbH
  • 17.21. Privi Speciality Chemicals Ltd.
  • 17.22. Royal DSM N.V.
  • 17.23. Shandong Stevio Bio-Tech Co., Ltd.
  • 17.24. Solvay S.A.
  • 17.25. Symrise AG
  • 17.26. TCI Chemicals
  • 17.27. Toagosei Co., Ltd.
  • 17.28. Vigon International, Inc.
  • 17.29. Zhejiang Xinan Chemical Industrial Group Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ICARIDIN TECHNICAL MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ICARIDIN TECHNICAL MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ICARIDIN TECHNICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ICARIDIN TECHNICAL MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY LOTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY LOTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY LOTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY AEROSOL SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY AEROSOL SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY AEROSOL SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY PUMP SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY PUMP SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY PUMP SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY WIPE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY WIPE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY WIPE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY COMPANY WEBSITE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY COMPANY WEBSITE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY E COMMERCE MARKETPLACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY E COMMERCE MARKETPLACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY E COMMERCE MARKETPLACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY SUPERMARKETS AND HYPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY OUTDOOR RECREATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY OUTDOOR RECREATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY OUTDOOR RECREATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY TRAVEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY TRAVEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY TRAVEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY COMMERCIAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY COMMERCIAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY COMMERCIAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY INSTITUTIONAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY INSTITUTIONAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY INSTITUTIONAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY PERSONAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY PERSONAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY PERSONAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ICARIDIN TECHNICAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. MIDDLE EAST ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 146. GCC ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. GCC ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 167. G7 ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. G7 ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 169. G7 ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 170. G7 ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. G7 ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 174. NATO ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 175. NATO ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. NATO ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 177. NATO ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 178. NATO ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. NATO ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL ICARIDIN TECHNICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ICARIDIN TECHNICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. CHINA ICARIDIN TECHNICAL MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CHINA ICARIDIN TECHNICAL MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 191. CHINA ICARIDIN TECHNICAL MARKET SIZE, BY SPRAY, 2018-2032 (USD MILLION)
  • TABLE 192. CHINA ICARIDIN TECHNICAL MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. CHINA ICARIDIN TECHNICAL MARKET SIZE, BY ONLINE RETAIL, 2018-2032 (USD MILLION)
  • TABLE 194. CHINA ICARIDIN TECHNICAL MARKET SIZE, BY PHARMACY AND DRUG STORES, 2018-2032 (USD MILLION)
  • TABLE 195. CHINA ICARIDIN TECHNICAL MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. CHINA ICARIDIN TECHNICAL MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)